Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Led by University of Sao Paulo · Updated on 2024-12-09
40
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Systemic autoimmune myopathies are rheumatic diseases affecting the striated skeletal muscles, including types such as polymyositis, dermatomyositis, and immune-mediated necrotizing myopathy. These diseases often cause significant muscle weakness and disability, despite improvements in pharmacological treatments. Researchers are evaluating the safety and effectiveness of chronic transcranial direct current stimulation combined with aerobic exercises in people with these myopathies through a prospective, randomized, double-blind, placebo-controlled study.
Participants are assigned to one of two groups: one receives transcranial direct current stimulation while performing aerobic exercises, and the other performs aerobic exercises alone without stimulation. The stimulation involves applying a mild electrical current of 2mA through electrodes placed on the head over the primary motor cortex for 20 minutes during the exercise session. Each participant completes a total of 10 sessions.
During the study, researchers monitor safety by tracking treatment-emergent adverse events before, immediately after, and at multiple points up to 300 days following the last stimulation session. Muscle disease activity, muscle enzyme levels, physical function, fatigue, pain, and global activity are assessed at the same intervals using various scales and physical tests. This comprehensive monitoring aims to evaluate both safety and potential benefits over time for up to nearly a year after treatment.
CONDITIONS
Brief Title
Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Who Can Participate
Age: 18Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
Meet classification criteria according to EULAR/ACR 2017
Meet classification criteria according to Connors et al.
You will not qualify if you...
Have neoplasia (cancer)
Use a heart pacemaker
Have metallic clips inside the body
Have infections such as HIV, HTLV-1, Hepatitis
Are pregnant
Have a history of seizures or epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Duration of 10 sessions
Participants receive 10 sessions of transcranial direct current stimulation combined with aerobic exercises or sham stimulation with aerobic exercises.
10 visits (in-person)
Follow-up
Duration - Up to 300 days after last stimulation session
Participants are monitored for safety and efficacy up to 300 days after the last stimulation session.
Visits at immediate, 30, 60, 90, and 300 days after last session
Impact of Transcranial Direct Current Stimulation in Pain, Fatigue, and Health Quality of Life of Patients with Idiopathic Inflammatory Myopathies: A Randomized, Double-Blind, Sham-Controlled Crossover Clinical Trial.
Rafael Giovani Missé, Alexandre Moura Dos Santos, Isabela Bruna Pires Borges...